133 related articles for article (PubMed ID: 32911471)
1. Calcium Influx Kinetics and the Characteristics of Potassium Channels in Peripheral T Lymphocytes in Systemic Sclerosis.
Toldi G; Legány N; Ocsovszki I; Balog A
Pathobiology; 2020; 87(5):311-316. PubMed ID: 32911471
[TBL] [Abstract][Full Text] [Related]
2. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
[TBL] [Abstract][Full Text] [Related]
3. Calcium influx kinetics, and the features of potassium channels of peripheral lymphocytes in primary Sjögren's syndrome.
Legány N; Toldi G; Orbán C; Megyes N; Bajnok A; Balog A
Immunobiology; 2016 Nov; 221(11):1266-72. PubMed ID: 27346388
[TBL] [Abstract][Full Text] [Related]
4. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
[TBL] [Abstract][Full Text] [Related]
5. Analysis by flow cytometry of calcium influx kinetics in peripheral lymphocytes of patients with rheumatoid arthritis.
Bajnok A; Kaposi A; Kovács L; Vásárhelyi B; Balog A; Toldi G
Cytometry A; 2013 Mar; 83(3):287-93. PubMed ID: 23335202
[TBL] [Abstract][Full Text] [Related]
6. Impact of aging on calcium influx and potassium channel characteristics of T lymphocytes.
Kollár S; Berta L; Vásárhelyi ZE; Balog A; Vásárhelyi B; Rigó J; Toldi G
Oncotarget; 2015 May; 6(15):13750-6. PubMed ID: 25948778
[TBL] [Abstract][Full Text] [Related]
7. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon β.
Toldi G; Folyovich A; Simon Z; Zsiga K; Kaposi A; Mészáros G; Tulassay T; Vásárhelyi B
J Neuroimmunol; 2011 Aug; 237(1-2):80-6. PubMed ID: 21764463
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.
Toldi G; Vásárhelyi B; Kaposi A; Mészáros G; Pánczél P; Hosszufalusi N; Tulassay T; Treszl A
Immunol Lett; 2010 Sep; 133(1):35-41. PubMed ID: 20603149
[TBL] [Abstract][Full Text] [Related]
10. The effects of Kv1.3 and IKCa1 channel inhibition on cytokine production and calcium influx of T lymphocytes in rheumatoid arthritis and ankylosing spondylitis.
Toldi G; Munoz L; Herrmann M; Schett G; Balog A
Immunol Res; 2016 Apr; 64(2):627-31. PubMed ID: 26280090
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia.
Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B
Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894
[TBL] [Abstract][Full Text] [Related]
12. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.
Wulff H; Calabresi PA; Allie R; Yun S; Pennington M; Beeton C; Chandy KG
J Clin Invest; 2003 Jun; 111(11):1703-13. PubMed ID: 12782673
[TBL] [Abstract][Full Text] [Related]
13. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns.
Orbán C; Szabó D; Bajnok A; Vásárhelyi B; Tulassay T; Arató A; Veres G; Toldi G
Oncotarget; 2016 Jul; 7(29):44966-44974. PubMed ID: 27329601
[TBL] [Abstract][Full Text] [Related]
14. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
[TBL] [Abstract][Full Text] [Related]
15. Potassium channels in T lymphocytes: therapeutic targets for autoimmune disorders?
Vianna-Jorge R; Suarez-Kurtz G
BioDrugs; 2004; 18(5):329-41. PubMed ID: 15377175
[TBL] [Abstract][Full Text] [Related]
16. Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke.
Folyovich A; Biro E; Orban C; Bajnok A; Vasarhelyi B; Toldi G
CNS Neurol Disord Drug Targets; 2014; 13(5):801-6. PubMed ID: 25012622
[TBL] [Abstract][Full Text] [Related]
17. Altered activation of peripheral CD8+ T cells in pediatric Crohn's disease.
Orbán C; Szabó D; Bajnok A; Vásárhelyi B; Tulassay T; Arató A; Veres G; Toldi G
Immunol Lett; 2017 May; 185():48-51. PubMed ID: 28300604
[TBL] [Abstract][Full Text] [Related]
18. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
[TBL] [Abstract][Full Text] [Related]
19. Potassium channels as therapeutic targets for autoimmune disorders.
Wulff H; Beeton C; Chandy KG
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.
Fujii H; Hasegawa M; Takehara K; Mukaida N; Sato S
Clin Exp Immunol; 2002 Dec; 130(3):548-56. PubMed ID: 12452848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
